Transformation of the clinical trials industry is upon us – stay ahead of the curve and discover the emerging vendor landscape for accessible & representative studies.
With the FDA requiring improved diversity in clinical trials to ensure clinical data is generalizable to all populations – the flood gates have opened for new market opportunities and a mass of innovative start-ups has emerged.
What you can Expect:
The Complete Industry Landscape
Understand how vendors are collaborating with pharmaceutical companies to address bottlenecks in clinical trial diversity & tackle recruitment access barriers.
The Commercial Case for Health Equity
Learn how ROI is demonstrated by metric reporting, accelerating recruitment, and avoiding regulatory delays.
Immersed Investors & Scaling Start-up
Meet with companies already investing in the digital health and life sciences health equity market and understand the value proposition from pharma and start-ups alike.
New for 2025: Start-ups & Investors Private Lunch
Ensure you meet rapidly growing SMEs and disruptive start ups using a whole range of tools to engage with underrepresented populations including EHR services, Predictive AI, social media analytics, language & literacy providers and more. Uncover proof of concept and build your knowledge of this sector.
